Can the Brinkman Index Predict the Need for Treatment in Patients With COVID-19?

Abstract

Get full access to this article

View all access options for this article.

References

National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. Evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19. Centers for Disease Control and Prevention. February 15, 2022. Accessed January 3, 2022. https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/underlying-evidence-table.html#print.

Brinkman

Coates

Jr.

The effect of bronchitis, smoking, and occupation on ventilation. Am Rev Respir Dis. 1963;87:684-693.

Kanda

. Investigation of the freely available easy-to-use software “EZR” (Easy R) for medical statistics. Bone Marrow Transplant. 2013;48:452-458.

Patanavanich

Glantz

. Smoking is associated with COVID-19 progression: a meta-analysis. Nicotine Tob Res. 2020;22(9):1653-1656.

Maeshima

Tochigi

Tsuta

Asamura

Matsuno

. Histological evaluation of the effect of smoking on peripheral small adenocarcinomas of the lung. J Thorac Oncol. 2008;3(7):698-703.

Kojima

Sakakibara

Motani

Hirose

Mizuno

Ito

, et al. Effects of smoking and age on chronic obstructive pulmonary disease in Japan. J Epidemiol. 2005;15(4):113-117.

Lowe

Zein

Hatipoglu

Attaway

. Association of smoking and cumulative pack-year exposure with COVID-19 outcomes in the Cleveland Clinic COVID-19 registry. JAMA Intern Med. 2021;181(5):709-711.

Matsushita

Yokoyama

Hayakawa

, et al. Smoking and severe illness in hospitalized COVID-19 patients in Japan [published online ahead of print December 11, 2021]. Int J Epidemiol. doi:10.1093/ije/dyab254.